Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all


IAVI recognizes HIV Vaccine Awareness Day as new papers are published

May 17, 2024

Additional evidence advances germline targeting strategy for HIV vaccine development

Read more

In The News

New Lassa vaccine trial puts African experts at the helm

The Guardian Nigeria

May 15, 2024

Read more


IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

May 7, 2024

Lab to close June 30, 2024

Read more


TB vaccine workshop report published in Frontiers in Tuberculosis

May 2, 2024

Workshop examined high-burden country data needs for future TB vaccine introduction

Read more

IAVI Report

Rethinking antibodies for infectious diseases?

April 23, 2024

The COVID-19 experience, along with lingering manufacturing and delivery concerns, is prompting a harder look at the future of antibody-based treatment and prevention for infectious diseases.

Read more

Press Releases

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate

Read more


World Vaccine Congress highlights IAVI’s R&D from end to end

March 29, 2024

IAVI leaders to share updates on our emerging infectious disease R&D portfolio and our work to make much-needed vaccines and antibodies globally accessible

Read more

Scientific Publications

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

Read more